The LNGFR (+) THY-1 (+) cells showed the characteristics of non-myelinating Schwan precursor cells in neural crest maintenance medium. Cells also partially expressed mesenchymal stem cells markers and developed into mature mesenchymal lineages including osteocyte, chondrocyte and adipocyte under each appropriate condition.
The LNGFR (+) THY-1 (+) cells showed the characteristics of non-myelinating Schwan precursor cells in neural crest maintenance medium. Cells also partially expressed mesenchymal stem cells markers and developed into mature mesenchymal lineages including osteocyte, chondrocyte and adipocyte under each appropriate condition.
In order to evaluate the differentiation potential in vivo, the LNGFR (+) THY-1 (+) cells were injected into the chick embryo and the humanized immunodeficient adult mice. Transplanted LNGFR (+) THY-1 (+) cells survived in vivo, and they can generate the various types of mature cells.
The present study shows that human iPS cells-derived LNGFR (+) THY-1 (+) cells have multipotent differentiation ability in vitro, and migration and environmental adaptation capacity in vivo. Taken together, these results suggest that LNGFR (+) THY-1 (+) identified following neural crest-like cells induction from iPS cells shared potentials with multipotent MSCs. Human pluripotent stem cells (hPSCs) have the remarkable differentiation and self-organization ability to mimic early embryonic tissue development. However, hPSC tissue patterning is often spontaneous in conventional spheroid or monolayer cultures, which limits their translation into standardized experimental models for developmental diseases. Therefore, to direct tissue patterning in vitro, it is imperative to apply the spatio-temporal principles underlying early embryonic development in vivo that facilitate a controlled tissue patterning. Recent advances using stem cell micropatterning techniques have provided a spatial control over hPSC differentiation fates, however, there aren't any reports on the formation of a spatially organized hPSC structure that can be related to human diseases.
Here, we demonstrate the directed formation of a spatially patterned 3D neuroepithelium (NE) structure from hPSCs. In vivo, defects in the normal folding of the NE into the neural tube are manifested as a common class of birth defects known as neural tube defects. We combined cell micropatterning and a multi-step induction protocol to achieve spatio-temporal control over hPSC differentiation. The micropatterned PSCs were induced to undergo a mesoendoderm pre-patterning step before NE induction to mimic the temporal embryonic developmental events, where mesoendoderm precedes neuroectoderm differentiation. Mesoendoderm induction of hPSC micropatterns resulted in the temporal expression of the mesoendoderm marker, T, at the periphery of the hPSC micropattern, surrounding a Sox2 + ectoderm inner layer. Upon NE induction of the mesoendoderm-primed micropatterned colonies, we observed the formation of an organized annular ring of Sox2 + / Nestin + 3D NE structure. In a similar experimental setup, lack of mesoendoderm pre-priming prior to NE induction of hPSC micropatterns resulted in disorganized 3D NE structure. This suggests that pre-patterned ME cells at the periphery of the micropatterned hPSC colony may provide organizational cues to direct NE differentiation and morphogenesis similar to in vivo conditions. We foresee this research as an important direction in 3D neuroepithelium tissue patterning with better-controlled organization and, therefore, function. Introduction: Bone marrow mononuclear stem cells have several advantages for clinical applications, as they can be easily obtained and are suitable for autologous transplantation. In this study we evaluated the feasibility, safety and potential efficacy of autologous transplantation of autologous bone marrow mononuclear stem cells in subjects with acute complete SCI.
Method: We conducted a phase I, randomized controlled study in patients with acute complete (quadriplegia/ paraplegia) traumatic SCI (within 21 days), classified as American Spinal Injury Association (ASIA) grade-A. Patients were randomized to standard therapy arm or a standard therapy plus stem cell arm.
Baseline spinal magnetic resonance imaging (MRI) and Spinal Cord Independence Measure (SCIM) were assessed before and at 6 months and 1 year after treatment. Bone marrow was aspirated and mononuclear stem cells were isolated and characterized by flow cytometry. Bone marrow mononuclear stem cells were injected directly into the spinal cord at the level of the injury following a dural incision after decompression of the cord and instrumentation (if required).
Results: A total of 14 patients were randomized to the stem cell arm (n =7) or the control arm (n =7). Both groups were comparable in level of injury, demographics and follow up period. The mean follow up period was 8 months (range 3-12 months) in stem cell group and 9 months in control group (range 3-12 months). All subjects in stem cell group displayed variable improvements in sensory function and six subjects developed lower limbs motor functional gains, principally in the hip flexors. ASIA grade improved by one grade in 1 patient,by 2 grades in 4 patients and 3 grades in 1 patients. SCIM scores improved by mean of 24 (range 10-43). No patient in control group had any improvement in ASIA grade or sensory function. Intramedullary injection of stem cells was not associated with any adverse events in any patient.
Conclusion: Intramedullary transplantation of autologous bone marrow mononuclear stem cells in subjects with acute complete spinal cord injury is safe, feasible and may promote improvement in motor and sensory function. The mouse continuously growing front tooth (incisor) serves as a valuable model to study stem cells (SCs) at the molecular, cellular and evolutionary levels.
